The landscape of dementia analysis has evolved substantially with the appearance of complex biomarkers, which include amyloid PET scans, tau imaging, and blood-based mostly tests that may detect Alzheimer's pathology many years before symptoms arise. Although these technological developments represent remarkable development in knowing neurodegenerative illnesses, they may have not https://dennisd208fqz8.life-wiki.com/user